MiT family translocation carcinomas
This page is under construction |
Contributors
Tumor Type
Tumor Classification
Description
IHC Markers
Genomic Gain/Loss/LOH
Chromosome | Gain/Loss/Amp | Region |
---|---|---|
1 | Loss | Chr1 |
2 | Loss | Chr14 |
3 | Loss | Chr21 |
4 | Loss | ChrX |
5 | Loss | ChrY (male) |
Rearrangements
Mutations (SNV/INDEL)
From Cosmic Mutated in >20%
Mutated in 10-20%
Mutated in 5-10%
Mutated in 2-5%
mtDNA
Epigenomics (methylation)
Main Pathways Involved
Diagnosis
Prognosis
Therapeutics
Write your comments here